Autopsy report · NCT07156006

Breast Arterial Calcifications as an Imaging Biomarker of Cardiovascular Risk

“PI ceased activity”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 4 months after it had already started.
• Ran for about 3 years 8 months before it stopped.
• 149 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

IRCCS Policlinico S. Donato

Sponsor type

University, hospital or other

Conditions

Breast; Cardiovascular Calcification

Interventions

Mammography

Participants

149

Sites

1

Countries

Italy

Trials that died the same way

• Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation
  “PI no longer at this facility” (72% match in meaning)
• Coping, Perceived Meaning, Joy, Horizontal Civility at Work
  “PI no longer at institution” (71% match in meaning)
• Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib
  “PI decided not to proceed” (71% match in meaning)
• Analysis of Cardiac Biomarker Racial Discrepancies
  “PI no longer with the site” (70% match in meaning)
• Phototherapy in DM Amputation Ulcers.
  “The PI is no longer working at UniNove” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.